Browsing by Author Supparatpinyo K.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 17 to 36 of 47 < previous   next >
Issue DateTitleAuthor(s)
2009Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitisManosuthi W.; Sungkanuparph S.; Anekthananon T.; Supparatpinyo K.; Nolen T.L.; Zimmer L.O.; Pappas P.G.; Larsen R.A.; Filler S.G.; Chetchotisakd P.
1992An efficacy study of itraconazole in the treatment of Penicillium marneffei infectionSupparatpinyo K.; Chiewchanvit S.; Hirunsri P.; Baosoung V.; Uthammachai C.; Chaimongkol B.; Sirisanthana T.
-Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patientsSirisanthana T.; Supparatpinyo K.
2011Epidemiology of adult candidemia at Chiang Mai University HospitalChaiwarith R.; Ounbang P.; Khamwan C.; Nuntachit N.; Sirisanthana T.; Supparatpinyo K.
2008Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: The recommendations of the thai AIDS society (TAS) 2008Sungkanuparph S.; Anekthananon T.; Hiransuthikul N.; Bowonwatanuwong C.; Supparatpinyo K.; Mootsikapun P.; Chetchotisakd P.; Kiertiburanakul S.; Tansuphaswadikul S.; Buppanharun W.; Manosuthi W.; Techasathit W.; Ratanasuwan W.; Tantisiriwat W.; Suwanagool S.; Leechawengwongs M.; Ruxrungtham K.
2011Impact of HIV-1 viral load on genotypic characteristics among patients failing non-nucleoside reverse trancriptase inhibitor-based first-line regimens in Northern ThailandPraparattanapan J.; Kotarathitithum W.; Chaiwarith R.; Nuntachit N.; Sirsisanthana T.; Supparatpinyo K.; Tragoolpua Y.
2011Impact of HIV-1 viral load on genotypic characteristics among patients failing non-nucleoside reverse trancriptase inhibitor-based first-line regimens in Northern ThailandPraparattanapan J.; Kotarathitithum W.; Chaiwarith R.; Nuntachit N.; Sirsisanthana T.; Supparatpinyo K.; Tragoolpua Y.
2011Impact of the frequency of plasma HIV-1 RNA monitoring on the outcome of antiretroviral therapyChaiwarith R.; Praparattanapan J.; Nuntachit N.; Kotarathitithum W.; Sirisanthana T.; Supparatpinyo K.
2013Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AEDokuta S.; Utaipat U.; Praparattanapan J.; Keitkarn J.; Maneekarn N.; Sirisanthana T.; Supparatpinyo K.
2011Incidence and risk factors of antiretroviral treatment failure in treatment-naïve HIV-infected patients at Chiang Mai University Hospital, ThailandKhienprasit N.; Chaiwarith R.; Sirisanthana T.; Supparatpinyo K.
2011Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in ThailandChaiwarith R.; Fakthongyoo A.; Praparattanapan J.; Boonmee D.; Sirisanthana T.; Supparatpinyo K.
2009Long-term CD4 cell count recovery among Thai naive HIV-infected patients initiating HAART at low CD4 cell countChaiwarith R.; Salee P.; Kotarathitithum W.; Sirisanthana T.; Supparatpinyo K.
1-Jan-2015Lopinavir/ritonavir monotherapy as second-line antiretroviral treatment in resource-limited settings: Week 104 analysis of AIDS clinical trials group (ACTG) A5230Kumarasamy N.; Aga E.; Ribaudo H.; Wallis C.; Katzenstein D.; Stevens W.; Norton M.; Klingman K.; Hosseinipour M.; Crump J.; Supparatpinyo K.; Badal-Faesen S.; Bartlett J.
2002Lymphadenopathy due to Penicillium marneffei infection: Diagnosis by fine needle aspiration cytologyChaiwun B.; Khunamornpong S.; Sirivanichai C.; Rangdaeng S.; Supparatpinyo K.; Settakorn J.; Ya-in C.; Thorner P.
2007Maltreatment of Strongyloides Infection: Case Series and Worldwide Physicians-in-Training SurveyBoulware D.R.; Stauffer W.M.; Hendel-Paterson B.R.; Rocha J.L.L.; Seet R.C.-S.; Summer A.P.; Nield L.S.; Supparatpinyo K.; Chaiwarith R.; Walker P.F.
1-Nov-2012Penicilliosis MarneffeiSupparatpinyo K.
2013Penicillium marneffei Infection in Immunocompromised HostChitasombat M.; Supparatpinyo K.
2009A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitisPappas P.G.; Chetchotisakd P.; Larsen R.A.; Manosuthi W.; Morris M.I.; Anekthananon T.; Sungkanuparph S.; Supparatpinyo K.; Nolen T.L.; Zimmer L.O.; Kendrick A.S.; Johnson P.; Sobel J.D.; Filler S.G.
2011Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patientsAnekthananon T.; Manosuthi W.; Chetchotisakd P.; Kiertiburanakul S.; Supparatpinyo K.; Ratanasuwan W.; Pappas P.G.; Filler S.G.; Kopetskie H.A.; Nolen T.L.; Kendrick A.S.; Larsen R.A.
1-Jan-2015Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated with Virologic Failure: Results from the Multinational PEARLS (ACTG A5175) Clinical TrialKantor R.; Smeaton L.; Vardhanabhuti S.; Hudelson S.; Wallis C.; Tripathy S.; Morgado M.; Saravanan S.; Balakrishnan P.; Reitsma M.; Hart S.; Mellors J.; Halvas E.; Grinsztejn B.; Hosseinipour M.; Kumwenda J.; La Rosa A.; Lalloo U.; Lama J.; Rassool M.; Santos B.; Supparatpinyo K.; Hakim J.; Flanigan T.; Kumarasamy N.; Campbell T.; Eshleman S.